Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity

Jane B. Laursen; Peter C. De Visser; Henrik K. Nielsen; Knud J. Jensen; John Nielsen

doi:10.1016/S0960-894X(01)00692-8

Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity

Jane B. Laursen, Peter C. De Visser, Henrik K. Nielsen, Knud J. Jensen, John Nielsen^*

^*Corresponding author af dette arbejde

20 Citationer (Scopus)

Abstract

An array of 12 new saphenamycin analogues modified at the benzoate moiety was synthesized on solid support. Synthesis commenced with a chemoselective anchoring of saphenic acid through the carboxyl group to a 2-chlorotrityl functionalized polystyrene resin. The secondary alcohol was acylated in parallel with a series of differently substituted benzoic acid derivatives. Treatment with TFA-CH₂Cl₂ (5:995) released the expected saphenamycin analogues into solution. These new analogues were purified, characterized and screened for antimicrobial activity against Bacillus subtilis and Proteus mirabilis. Eight analogues exhibited MIC values against B. subtilis ranging from 0.07 to 3.93 μg/mL, comparable to the activities of previously reported saphenamycin analogues.

Originalsprog	Engelsk
Tidsskrift	Bioorganic and Medicinal Chemistry Letters
Vol/bind	12
Udgave nummer	2
Sider (fra-til)	171-175
Antal sider	5
ISSN	0960-894X
DOI	https://doi.org/10.1016/S0960-894X(01)00692-8
Status	Udgivet - 21 jan. 2002

Adgang til dokumentet

10.1016/S0960-894X(01)00692-8

http://www.scopus.com/inward/record.url?scp=0037147788&partnerID=8YFLogxK

Citationsformater

@article{ffdbaa79205b481c88cae27f967703c9,

title = "Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity",

abstract = "An array of 12 new saphenamycin analogues modified at the benzoate moiety was synthesized on solid support. Synthesis commenced with a chemoselective anchoring of saphenic acid through the carboxyl group to a 2-chlorotrityl functionalized polystyrene resin. The secondary alcohol was acylated in parallel with a series of differently substituted benzoic acid derivatives. Treatment with TFA-CH2Cl2 (5:995) released the expected saphenamycin analogues into solution. These new analogues were purified, characterized and screened for antimicrobial activity against Bacillus subtilis and Proteus mirabilis. Eight analogues exhibited MIC values against B. subtilis ranging from 0.07 to 3.93 μg/mL, comparable to the activities of previously reported saphenamycin analogues.",

author = "Laursen, {Jane B.} and {De Visser}, {Peter C.} and Nielsen, {Henrik K.} and Jensen, {Knud J.} and John Nielsen",

year = "2002",

month = jan,

day = "21",

doi = "10.1016/S0960-894X(01)00692-8",

language = "English",

volume = "12",

pages = "171--175",

journal = "Bioorganic & Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Pergamon Press",

number = "2",

}

TY - JOUR

T1 - Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity

AU - Laursen, Jane B.

AU - De Visser, Peter C.

AU - Nielsen, Henrik K.

AU - Jensen, Knud J.

AU - Nielsen, John

PY - 2002/1/21

Y1 - 2002/1/21

N2 - An array of 12 new saphenamycin analogues modified at the benzoate moiety was synthesized on solid support. Synthesis commenced with a chemoselective anchoring of saphenic acid through the carboxyl group to a 2-chlorotrityl functionalized polystyrene resin. The secondary alcohol was acylated in parallel with a series of differently substituted benzoic acid derivatives. Treatment with TFA-CH2Cl2 (5:995) released the expected saphenamycin analogues into solution. These new analogues were purified, characterized and screened for antimicrobial activity against Bacillus subtilis and Proteus mirabilis. Eight analogues exhibited MIC values against B. subtilis ranging from 0.07 to 3.93 μg/mL, comparable to the activities of previously reported saphenamycin analogues.

AB - An array of 12 new saphenamycin analogues modified at the benzoate moiety was synthesized on solid support. Synthesis commenced with a chemoselective anchoring of saphenic acid through the carboxyl group to a 2-chlorotrityl functionalized polystyrene resin. The secondary alcohol was acylated in parallel with a series of differently substituted benzoic acid derivatives. Treatment with TFA-CH2Cl2 (5:995) released the expected saphenamycin analogues into solution. These new analogues were purified, characterized and screened for antimicrobial activity against Bacillus subtilis and Proteus mirabilis. Eight analogues exhibited MIC values against B. subtilis ranging from 0.07 to 3.93 μg/mL, comparable to the activities of previously reported saphenamycin analogues.

U2 - 10.1016/S0960-894X(01)00692-8

DO - 10.1016/S0960-894X(01)00692-8

M3 - Journal article

C2 - 11755347

AN - SCOPUS:0037147788

SN - 0960-894X

VL - 12

SP - 171

EP - 175

JO - Bioorganic & Medicinal Chemistry Letters

JF - Bioorganic & Medicinal Chemistry Letters

IS - 2

ER -

Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater